Effects of inflammation and oxidative stress on postoperative delirium in cardiac surgery

Yi Pang, Yuntao Li, Yonggang Zhang, Hongfa Wang, Junhui Lang, Liang Han, He Liu, Xiaoxing Xiong, Lijuan Gu, Xiaomin WuFrontiers in Cardiovascular Medicine 2022 · DOI

TL;DR

Postoperative delirium (POD) is a frequent and severe complication of cardiac surgery, yet its underlying mechanisms remain elusive. This review synthesizes current evidence suggesting that systemic inflammation and oxidative stress—triggered by surgical trauma and the use of cardiopulmonary bypass—are the primary drivers of the neural damage leading to delirium.

What Problem Does This Paper Address?

As cardiac surgeries become more common and technically safe, the medical community is grappling with "hidden" complications like postoperative delirium (POD). POD is an acute state of confusion and cognitive decline that affects between 10% and 72% of cardiac surgery patients, depending on the procedure.

The stakes are high: patients who develop POD face higher mortality rates, permanent cognitive impairment, and longer hospital stays. While clinicians have identified various risk factors (like advanced age or pre-existing disease), the actual biological "trigger" that turns a successful heart surgery into a brain-function crisis is not fully understood. This paper investigates the "Inflammatory Hypothesis"—the idea that the body’s massive immune response to heart surgery inadvertently breaches the blood-brain barrier and disrupts neuronal function.

Methods

This is a comprehensive review article. Rather than presenting a single new experiment, the authors systematically synthesize findings from dozens of clinical trials and biochemical studies. They categorize the evidence into three main pillars:

  1. Pathophysiology: Mapping how surgical triggers (like the heart-lung machine) lead to systemic inflammation.
  2. Risk Factors: Distinguishing between pre-operative "predisposing" factors and intra-operative "precipitating" factors.
  3. Pharmacological Interventions: Evaluating the efficacy of drugs like statins, melatonin, and sedatives in preventing POD.

Datasets

As a review paper, it does not introduce a new dataset. However, it provides a meta-summary (Table 1) of 15 major clinical studies involving over 7,000 total patients. These studies cover various cardiac procedures, including:

  • CABG: Coronary Artery Bypass Grafting.
  • AD: Aortic Dissection repair.
  • SAVR/TAVR: Aortic valve replacements.
  • MVR: Mitral valve repair.

The review notes that the wide range in reported POD incidence (3.1% to 72%) is likely due to differences in surgical complexity and the specific delirium assessment tools used (e.g., CAM-ICU vs. DSM criteria).

Key Insights and Ideas

  • The "Foreign Surface" Trigger: Cardiopulmonary bypass (CPB) is a primary activator of inflammation. When blood contacts the foreign plastic surfaces of the CPB circuit, it triggers a massive release of cytokines (like IL-6 and TNF-α).
  • Ischemia-Reperfusion Injury: When blood flow is restored to the heart after a period of stoppage, it creates a "burst" of Reactive Oxygen Species (ROS). These unstable molecules cause oxidative stress, damaging cellular membranes and proteins far beyond the heart itself.
  • The Leaky Brain Barrier: Systemic inflammation increases the permeability of the Blood-Brain Barrier (BBB). This allows inflammatory mediators to enter the central nervous system, activating microglia (the brain's immune cells) and leading to neuronal dysfunction.
  • The "Pump-Head" Debate: While POD was historically blamed entirely on the CPB machine (leading to the term "pump-head"), recent studies show similar delirium rates in "off-pump" surgeries. This suggests that surgical trauma and the body’s baseline inflammatory state are just as critical as the bypass machine itself.

Key Results

  • Incidence: POD is most prevalent in complex procedures like Aortic Dissection repair (up to 34%) and certain valve replacements.
  • Neuroprotection via Dexmedetomidine (DEX): Of all pharmacological interventions discussed, DEX (a sedative) shows the most consistent promise. Meta-analyses suggest it significantly reduces POD incidence compared to other sedatives like propofol, likely due to its anti-inflammatory and antioxidant properties.
  • Mixed Results for Statins and Melatonin: While theoretically beneficial, clinical evidence for statins and melatonin in preventing POD remains controversial and inconsistent across different patient populations.
  • Parecoxib Potential: This COX-2 inhibitor may offer neuroprotection by reducing ROS levels and inhibiting apoptosis (programmed cell death) in astrocytes, though more clinical validation is needed.

Limitations and Future Work

The authors acknowledge that the precise cellular pathways of POD remain a "black box." Key limitations and areas for future research include:

  • Biomarker Scarcity: Many inflammatory markers are not suitable for routine clinical risk assessment. There is an urgent need for reliable, fast-acting biomarkers to identify high-risk patients before they go under the knife.
  • Conflicting Data: The relationship between CPB duration and delirium is still debated, with different studies yielding opposite results.
  • Need for RCTs: Most current evidence comes from retrospective studies. Large-scale, randomized controlled trials (RCTs) are necessary to confirm if anti-inflammatory or antioxidant-based therapies can truly mitigate POD in a clinical setting.

Summary updated

Abstract

The past decade has witnessed unprecedented medical progress, which has translated into cardiac surgery being increasingly common and safe. However, complications such as postoperative delirium remain a major concern. Although the pathophysiological changes of delirium after cardiac surgery remain poorly understood, it is widely thought that inflammation and oxidative stress may be potential triggers of delirium. The development of delirium following cardiac surgery is associated with perioperative risk factors. Multiple interventions are being explored to prevent and treat delirium. Therefore, research on the potential role of biomarkers in delirium as well as identification of perioperative risk factors and pharmacological interventions are necessary to mitigate the development of delirium.
BibTeX
@inproceedings{pang2022effects,
  author = {Yi Pang and Yuntao Li and Yonggang Zhang and Hongfa Wang and Junhui Lang and Liang Han and He Liu and Xiaoxing Xiong and Lijuan Gu and Xiaomin Wu},
  title = {{Effects of inflammation and oxidative stress on postoperative delirium in cardiac surgery}},
  booktitle = {Frontiers in Cardiovascular Medicine},
  year = {2022},
  doi = {10.3389/fcvm.2022.1049600},
}
Figure